Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 7/7/2025

Drug Interactions with Carbamazepine

Introduction to Carbamazepine Interactions

  • The American College of Cardiology and other medical societies recommend careful monitoring and dose adjustments when prescribing carbamazepine due to its numerous significant drug interactions that can affect both its own levels and the levels of other medications, potentially leading to toxicity or therapeutic failure 1

CYP3A4 Interactions

  • CYP3A4 inhibitors, such as macrolide antibiotics, antifungals, and certain antidepressants, can significantly increase plasma carbamazepine levels, potentially leading to toxicity 1
  • CYP3A4 inducers, such as other antiepileptics, rifampin, and cisplatin, can decrease carbamazepine levels, potentially reducing efficacy 2

Specific Drug Interactions

  • Valproic acid increases carbamazepine-10,11-epoxide concentrations, potentially causing toxicity, and requires therapeutic drug monitoring and possible dose adjustment 1
  • Digoxin levels are decreased by carbamazepine, requiring therapeutic drug monitoring and dose increases 1
  • Warfarin efficacy is decreased by carbamazepine, requiring monitoring of INR and dose adjustments 2
  • Rifampin significantly decreases carbamazepine levels 3
  • Isoniazid increases carbamazepine levels and risk of hepatotoxicity 1
  • Sofosbuvir-based regimens are contraindicated with carbamazepine due to significant reduction in DAA levels and potential treatment failure 4, 5
  • St. John's wort significantly decreases carbamazepine levels 4

Clinical Considerations

  • The American Heart Association recommends monitoring of INR and dose adjustments when carbamazepine is co-administered with warfarin 2
  • The European Association for the Study of the Liver recommends avoiding concomitant use of carbamazepine with sofosbuvir-based regimens due to significant reduction in DAA levels and potential treatment failure 4, 5
  • Biphasic interactions, such as those with phenytoin, may initially increase carbamazepine levels through protein displacement but later decrease levels through enzyme induction, highlighting the importance of careful monitoring and dose adjustments 2